The Anti-Migraine Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Anti-Migraine Drugs market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Women accounting for % of the Anti-Migraine Drugs global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Triptans segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Anti-Migraine Drugs include Eli Lilly, Abbott, Eisai, Allergan, and Endo, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Anti-Migraine Drugs market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
- Triptans
- Ergots
- Others
Market segment by Application can be divided into
- Women
- Men
The key market players for global Anti-Migraine Drugs market are listed below:
- Eli Lilly
- Abbott
- Eisai
- Allergan
- Endo
- GlaxoSmithKline
- Impax Laboratories
- Pfizer
- AstraZeneca
- Bayer
- Johnson & Johnson
- Merck
- Teva
- Amgen
Market segment by region, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Anti-Migraine Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Anti-Migraine Drugs, with price, sales, revenue and global market share of Anti-Migraine Drugs from 2019 to 2022.
Chapter 3, the Anti-Migraine Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Anti-Migraine Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Anti-Migraine Drugs market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Anti-Migraine Drugs.
Chapter 13, 14, and 15, to describe Anti-Migraine Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Global Anti-Migraine Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
Table of Contents
1 Market Overview
1.1 Anti-Migraine Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Anti-Migraine Drugs Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Triptans
1.2.3 Ergots
1.2.4 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Anti-Migraine Drugs Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Women
1.3.3 Men
1.4 Global Anti-Migraine Drugs Market Size & Forecast
1.4.1 Global Anti-Migraine Drugs Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Anti-Migraine Drugs Sales in Volume (2017-2028)
1.4.3 Global Anti-Migraine Drugs Price (2017-2028)
1.5 Global Anti-Migraine Drugs Production Capacity Analysis
1.5.1 Global Anti-Migraine Drugs Total Production Capacity (2017-2028)
1.5.2 Global Anti-Migraine Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Anti-Migraine Drugs Market Drivers
1.6.2 Anti-Migraine Drugs Market Restraints
1.6.3 Anti-Migraine Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Eli Lilly
2.1.1 Eli Lilly Details
2.1.2 Eli Lilly Major Business
2.1.3 Eli Lilly Anti-Migraine Drugs Product and Services
2.1.4 Eli Lilly Anti-Migraine Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Abbott
2.2.1 Abbott Details
2.2.2 Abbott Major Business
2.2.3 Abbott Anti-Migraine Drugs Product and Services
2.2.4 Abbott Anti-Migraine Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Eisai
2.3.1 Eisai Details
2.3.2 Eisai Major Business
2.3.3 Eisai Anti-Migraine Drugs Product and Services
2.3.4 Eisai Anti-Migraine Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Allergan
2.4.1 Allergan Details
2.4.2 Allergan Major Business
2.4.3 Allergan Anti-Migraine Drugs Product and Services
2.4.4 Allergan Anti-Migraine Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Endo
2.5.1 Endo Details
2.5.2 Endo Major Business
2.5.3 Endo Anti-Migraine Drugs Product and Services
2.5.4 Endo Anti-Migraine Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 GlaxoSmithKline
2.6.1 GlaxoSmithKline Details
2.6.2 GlaxoSmithKline Major Business
2.6.3 GlaxoSmithKline Anti-Migraine Drugs Product and Services
2.6.4 GlaxoSmithKline Anti-Migraine Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Impax Laboratories
2.7.1 Impax Laboratories Details
2.7.2 Impax Laboratories Major Business
2.7.3 Impax Laboratories Anti-Migraine Drugs Product and Services
2.7.4 Impax Laboratories Anti-Migraine Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Pfizer
2.8.1 Pfizer Details
2.8.2 Pfizer Major Business
2.8.3 Pfizer Anti-Migraine Drugs Product and Services
2.8.4 Pfizer Anti-Migraine Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 AstraZeneca
2.9.1 AstraZeneca Details
2.9.2 AstraZeneca Major Business
2.9.3 AstraZeneca Anti-Migraine Drugs Product and Services
2.9.4 AstraZeneca Anti-Migraine Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Bayer
2.10.1 Bayer Details
2.10.2 Bayer Major Business
2.10.3 Bayer Anti-Migraine Drugs Product and Services
2.10.4 Bayer Anti-Migraine Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Johnson & Johnson
2.11.1 Johnson & Johnson Details
2.11.2 Johnson & Johnson Major Business
2.11.3 Johnson & Johnson Anti-Migraine Drugs Product and Services
2.11.4 Johnson & Johnson Anti-Migraine Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Merck
2.12.1 Merck Details
2.12.2 Merck Major Business
2.12.3 Merck Anti-Migraine Drugs Product and Services
2.12.4 Merck Anti-Migraine Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Teva
2.13.1 Teva Details
2.13.2 Teva Major Business
2.13.3 Teva Anti-Migraine Drugs Product and Services
2.13.4 Teva Anti-Migraine Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Amgen
2.14.1 Amgen Details
2.14.2 Amgen Major Business
2.14.3 Amgen Anti-Migraine Drugs Product and Services
2.14.4 Amgen Anti-Migraine Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Anti-Migraine Drugs Breakdown Data by Manufacturer
3.1 Global Anti-Migraine Drugs Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Anti-Migraine Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Anti-Migraine Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Anti-Migraine Drugs Manufacturer Market Share in 2021
3.4.2 Top 6 Anti-Migraine Drugs Manufacturer Market Share in 2021
3.5 Global Anti-Migraine Drugs Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Anti-Migraine Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Anti-Migraine Drugs Market Size by Region
4.1.1 Global Anti-Migraine Drugs Sales in Volume by Region (2017-2028)
4.1.2 Global Anti-Migraine Drugs Revenue by Region (2017-2028)
4.2 North America Anti-Migraine Drugs Revenue (2017-2028)
4.3 Europe Anti-Migraine Drugs Revenue (2017-2028)
4.4 Asia-Pacific Anti-Migraine Drugs Revenue (2017-2028)
4.5 South America Anti-Migraine Drugs Revenue (2017-2028)
4.6 Middle East and Africa Anti-Migraine Drugs Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Anti-Migraine Drugs Sales in Volume by Type (2017-2028)
5.2 Global Anti-Migraine Drugs Revenue by Type (2017-2028)
5.3 Global Anti-Migraine Drugs Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Anti-Migraine Drugs Sales in Volume by Application (2017-2028)
6.2 Global Anti-Migraine Drugs Revenue by Application (2017-2028)
6.3 Global Anti-Migraine Drugs Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Anti-Migraine Drugs Sales by Type (2017-2028)
7.2 North America Anti-Migraine Drugs Sales by Application (2017-2028)
7.3 North America Anti-Migraine Drugs Market Size by Country
7.3.1 North America Anti-Migraine Drugs Sales in Volume by Country (2017-2028)
7.3.2 North America Anti-Migraine Drugs Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Anti-Migraine Drugs Sales by Type (2017-2028)
8.2 Europe Anti-Migraine Drugs Sales by Application (2017-2028)
8.3 Europe Anti-Migraine Drugs Market Size by Country
8.3.1 Europe Anti-Migraine Drugs Sales in Volume by Country (2017-2028)
8.3.2 Europe Anti-Migraine Drugs Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Anti-Migraine Drugs Sales by Type (2017-2028)
9.2 Asia-Pacific Anti-Migraine Drugs Sales by Application (2017-2028)
9.3 Asia-Pacific Anti-Migraine Drugs Market Size by Region
9.3.1 Asia-Pacific Anti-Migraine Drugs Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Anti-Migraine Drugs Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Anti-Migraine Drugs Sales by Type (2017-2028)
10.2 South America Anti-Migraine Drugs Sales by Application (2017-2028)
10.3 South America Anti-Migraine Drugs Market Size by Country
10.3.1 South America Anti-Migraine Drugs Sales in Volume by Country (2017-2028)
10.3.2 South America Anti-Migraine Drugs Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Anti-Migraine Drugs Sales by Type (2017-2028)
11.2 Middle East & Africa Anti-Migraine Drugs Sales by Application (2017-2028)
11.3 Middle East & Africa Anti-Migraine Drugs Market Size by Country
11.3.1 Middle East & Africa Anti-Migraine Drugs Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Anti-Migraine Drugs Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Anti-Migraine Drugs and Key Manufacturers
12.2 Manufacturing Costs Percentage of Anti-Migraine Drugs
12.3 Anti-Migraine Drugs Production Process
12.4 Anti-Migraine Drugs Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Anti-Migraine Drugs Typical Distributors
13.3 Anti-Migraine Drugs Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of Tables
Table 1. Global Anti-Migraine Drugs Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Anti-Migraine Drugs Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 4. Eli Lilly Major Business
Table 5. Eli Lilly Anti-Migraine Drugs Product and Services
Table 6. Eli Lilly Anti-Migraine Drugs Sales (K Units), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Abbott Basic Information, Manufacturing Base and Competitors
Table 8. Abbott Major Business
Table 9. Abbott Anti-Migraine Drugs Product and Services
Table 10. Abbott Anti-Migraine Drugs Sales (K Units), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Eisai Basic Information, Manufacturing Base and Competitors
Table 12. Eisai Major Business
Table 13. Eisai Anti-Migraine Drugs Product and Services
Table 14. Eisai Anti-Migraine Drugs Sales (K Units), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Allergan Basic Information, Manufacturing Base and Competitors
Table 16. Allergan Major Business
Table 17. Allergan Anti-Migraine Drugs Product and Services
Table 18. Allergan Anti-Migraine Drugs Sales (K Units), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Endo Basic Information, Manufacturing Base and Competitors
Table 20. Endo Major Business
Table 21. Endo Anti-Migraine Drugs Product and Services
Table 22. Endo Anti-Migraine Drugs Sales (K Units), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 24. GlaxoSmithKline Major Business
Table 25. GlaxoSmithKline Anti-Migraine Drugs Product and Services
Table 26. GlaxoSmithKline Anti-Migraine Drugs Sales (K Units), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Impax Laboratories Basic Information, Manufacturing Base and Competitors
Table 28. Impax Laboratories Major Business
Table 29. Impax Laboratories Anti-Migraine Drugs Product and Services
Table 30. Impax Laboratories Anti-Migraine Drugs Sales (K Units), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Pfizer Basic Information, Manufacturing Base and Competitors
Table 32. Pfizer Major Business
Table 33. Pfizer Anti-Migraine Drugs Product and Services
Table 34. Pfizer Anti-Migraine Drugs Sales (K Units), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 36. AstraZeneca Major Business
Table 37. AstraZeneca Anti-Migraine Drugs Product and Services
Table 38. AstraZeneca Anti-Migraine Drugs Sales (K Units), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Bayer Basic Information, Manufacturing Base and Competitors
Table 40. Bayer Major Business
Table 41. Bayer Anti-Migraine Drugs Product and Services
Table 42. Bayer Anti-Migraine Drugs Sales (K Units), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 44. Johnson & Johnson Major Business
Table 45. Johnson & Johnson Anti-Migraine Drugs Product and Services
Table 46. Johnson & Johnson Anti-Migraine Drugs Sales (K Units), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Merck Basic Information, Manufacturing Base and Competitors
Table 48. Merck Major Business
Table 49. Merck Anti-Migraine Drugs Product and Services
Table 50. Merck Anti-Migraine Drugs Sales (K Units), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Teva Basic Information, Manufacturing Base and Competitors
Table 52. Teva Major Business
Table 53. Teva Anti-Migraine Drugs Product and Services
Table 54. Teva Anti-Migraine Drugs Sales (K Units), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Amgen Basic Information, Manufacturing Base and Competitors
Table 56. Amgen Major Business
Table 57. Amgen Anti-Migraine Drugs Product and Services
Table 58. Amgen Anti-Migraine Drugs Sales (K Units), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Global Anti-Migraine Drugs Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 60. Global Anti-Migraine Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 61. Market Position of Manufacturers in Anti-Migraine Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 62. Global Anti-Migraine Drugs Production Capacity by Company, (K Units): 2020 VS 2021
Table 63. Head Office and Anti-Migraine Drugs Production Site of Key Manufacturer
Table 64. Anti-Migraine Drugs New Entrant and Capacity Expansion Plans
Table 65. Anti-Migraine Drugs Mergers & Acquisitions in the Past Five Years
Table 66. Global Anti-Migraine Drugs Sales by Region (2017-2022) & (K Units)
Table 67. Global Anti-Migraine Drugs Sales by Region (2023-2028) & (K Units)
Table 68. Global Anti-Migraine Drugs Revenue by Region (2017-2022) & (USD Million)
Table 69. Global Anti-Migraine Drugs Revenue by Region (2023-2028) & (USD Million)
Table 70. Global Anti-Migraine Drugs Sales by Type (2017-2022) & (K Units)
Table 71. Global Anti-Migraine Drugs Sales by Type (2023-2028) & (K Units)
Table 72. Global Anti-Migraine Drugs Revenue by Type (2017-2022) & (USD Million)
Table 73. Global Anti-Migraine Drugs Revenue by Type (2023-2028) & (USD Million)
Table 74. Global Anti-Migraine Drugs Price by Type (2017-2022) & (USD/Pcs)
Table 75. Global Anti-Migraine Drugs Price by Type (2023-2028) & (USD/Pcs)
Table 76. Global Anti-Migraine Drugs Sales by Application (2017-2022) & (K Units)
Table 77. Global Anti-Migraine Drugs Sales by Application (2023-2028) & (K Units)
Table 78. Global Anti-Migraine Drugs Revenue by Application (2017-2022) & (USD Million)
Table 79. Global Anti-Migraine Drugs Revenue by Application (2023-2028) & (USD Million)
Table 80. Global Anti-Migraine Drugs Price by Application (2017-2022) & (USD/Pcs)
Table 81. Global Anti-Migraine Drugs Price by Application (2023-2028) & (USD/Pcs)
Table 82. North America Anti-Migraine Drugs Sales by Country (2017-2022) & (K Units)
Table 83. North America Anti-Migraine Drugs Sales by Country (2023-2028) & (K Units)
Table 84. North America Anti-Migraine Drugs Revenue by Country (2017-2022) & (USD Million)
Table 85. North America Anti-Migraine Drugs Revenue by Country (2023-2028) & (USD Million)
Table 86. North America Anti-Migraine Drugs Sales by Type (2017-2022) & (K Units)
Table 87. North America Anti-Migraine Drugs Sales by Type (2023-2028) & (K Units)
Table 88. North America Anti-Migraine Drugs Sales by Application (2017-2022) & (K Units)
Table 89. North America Anti-Migraine Drugs Sales by Application (2023-2028) & (K Units)
Table 90. Europe Anti-Migraine Drugs Sales by Country (2017-2022) & (K Units)
Table 91. Europe Anti-Migraine Drugs Sales by Country (2023-2028) & (K Units)
Table 92. Europe Anti-Migraine Drugs Revenue by Country (2017-2022) & (USD Million)
Table 93. Europe Anti-Migraine Drugs Revenue by Country (2023-2028) & (USD Million)
Table 94. Europe Anti-Migraine Drugs Sales by Type (2017-2022) & (K Units)
Table 95. Europe Anti-Migraine Drugs Sales by Type (2023-2028) & (K Units)
Table 96. Europe Anti-Migraine Drugs Sales by Application (2017-2022) & (K Units)
Table 97. Europe Anti-Migraine Drugs Sales by Application (2023-2028) & (K Units)
Table 98. Asia-Pacific Anti-Migraine Drugs Sales by Region (2017-2022) & (K Units)
Table 99. Asia-Pacific Anti-Migraine Drugs Sales by Region (2023-2028) & (K Units)
Table 100. Asia-Pacific Anti-Migraine Drugs Revenue by Region (2017-2022) & (USD Million)
Table 101. Asia-Pacific Anti-Migraine Drugs Revenue by Region (2023-2028) & (USD Million)
Table 102. Asia-Pacific Anti-Migraine Drugs Sales by Type (2017-2022) & (K Units)
Table 103. Asia-Pacific Anti-Migraine Drugs Sales by Type (2023-2028) & (K Units)
Table 104. Asia-Pacific Anti-Migraine Drugs Sales by Application (2017-2022) & (K Units)
Table 105. Asia-Pacific Anti-Migraine Drugs Sales by Application (2023-2028) & (K Units)
Table 106. South America Anti-Migraine Drugs Sales by Country (2017-2022) & (K Units)
Table 107. South America Anti-Migraine Drugs Sales by Country (2023-2028) & (K Units)
Table 108. South America Anti-Migraine Drugs Revenue by Country (2017-2022) & (USD Million)
Table 109. South America Anti-Migraine Drugs Revenue by Country (2023-2028) & (USD Million)
Table 110. South America Anti-Migraine Drugs Sales by Type (2017-2022) & (K Units)
Table 111. South America Anti-Migraine Drugs Sales by Type (2023-2028) & (K Units)
Table 112. South America Anti-Migraine Drugs Sales by Application (2017-2022) & (K Units)
Table 113. South America Anti-Migraine Drugs Sales by Application (2023-2028) & (K Units)
Table 114. Middle East & Africa Anti-Migraine Drugs Sales by Region (2017-2022) & (K Units)
Table 115. Middle East & Africa Anti-Migraine Drugs Sales by Region (2023-2028) & (K Units)
Table 116. Middle East & Africa Anti-Migraine Drugs Revenue by Region (2017-2022) & (USD Million)
Table 117. Middle East & Africa Anti-Migraine Drugs Revenue by Region (2023-2028) & (USD Million)
Table 118. Middle East & Africa Anti-Migraine Drugs Sales by Type (2017-2022) & (K Units)
Table 119. Middle East & Africa Anti-Migraine Drugs Sales by Type (2023-2028) & (K Units)
Table 120. Middle East & Africa Anti-Migraine Drugs Sales by Application (2017-2022) & (K Units)
Table 121. Middle East & Africa Anti-Migraine Drugs Sales by Application (2023-2028) & (K Units)
Table 122. Anti-Migraine Drugs Raw Material
Table 123. Key Manufacturers of Anti-Migraine Drugs Raw Materials
Table 124. Direct Channel Pros & Cons
Table 125. Indirect Channel Pros & Cons
Table 126. Anti-Migraine Drugs Typical Distributors
Table 127. Anti-Migraine Drugs Typical Customers
List of Figures
Figure 1. Anti-Migraine Drugs Picture
Figure 2. Global Anti-Migraine Drugs Revenue Market Share by Type in 2021
Figure 3. Triptans
Figure 4. Ergots
Figure 5. Others
Figure 6. Global Anti-Migraine Drugs Revenue Market Share by Application in 2021
Figure 7. Women
Figure 8. Men
Figure 9. Global Anti-Migraine Drugs Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 10. Global Anti-Migraine Drugs Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Anti-Migraine Drugs Sales (2017-2028) & (K Units)
Figure 12. Global Anti-Migraine Drugs Price (2017-2028) & (USD/Pcs)
Figure 13. Global Anti-Migraine Drugs Production Capacity (2017-2028) & (K Units)
Figure 14. Global Anti-Migraine Drugs Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. Anti-Migraine Drugs Market Drivers
Figure 16. Anti-Migraine Drugs Market Restraints
Figure 17. Anti-Migraine Drugs Market Trends
Figure 18. Global Anti-Migraine Drugs Sales Market Share by Manufacturer in 2021
Figure 19. Global Anti-Migraine Drugs Revenue Market Share by Manufacturer in 2021
Figure 20. Anti-Migraine Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 Anti-Migraine Drugs Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 Anti-Migraine Drugs Manufacturer (Revenue) Market Share in 2021
Figure 23. Global Anti-Migraine Drugs Sales Market Share by Region (2017-2028)
Figure 24. Global Anti-Migraine Drugs Revenue Market Share by Region (2017-2028)
Figure 25. North America Anti-Migraine Drugs Revenue (2017-2028) & (USD Million)
Figure 26. Europe Anti-Migraine Drugs Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific Anti-Migraine Drugs Revenue (2017-2028) & (USD Million)
Figure 28. South America Anti-Migraine Drugs Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa Anti-Migraine Drugs Revenue (2017-2028) & (USD Million)
Figure 30. Global Anti-Migraine Drugs Sales Market Share by Type (2017-2028)
Figure 31. Global Anti-Migraine Drugs Revenue Market Share by Type (2017-2028)
Figure 32. Global Anti-Migraine Drugs Price by Type (2017-2028) & (USD/Pcs)
Figure 33. Global Anti-Migraine Drugs Sales Market Share by Application (2017-2028)
Figure 34. Global Anti-Migraine Drugs Revenue Market Share by Application (2017-2028)
Figure 35. Global Anti-Migraine Drugs Price by Application (2017-2028) & (USD/Pcs)
Figure 36. North America Anti-Migraine Drugs Sales Market Share by Type (2017-2028)
Figure 37. North America Anti-Migraine Drugs Sales Market Share by Application (2017-2028)
Figure 38. North America Anti-Migraine Drugs Sales Market Share by Country (2017-2028)
Figure 39. North America Anti-Migraine Drugs Revenue Market Share by Country (2017-2028)
Figure 40. United States Anti-Migraine Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada Anti-Migraine Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico Anti-Migraine Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe Anti-Migraine Drugs Sales Market Share by Type (2017-2028)
Figure 44. Europe Anti-Migraine Drugs Sales Market Share by Application (2017-2028)
Figure 45. Europe Anti-Migraine Drugs Sales Market Share by Country (2017-2028)
Figure 46. Europe Anti-Migraine Drugs Revenue Market Share by Country (2017-2028)
Figure 47. Germany Anti-Migraine Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France Anti-Migraine Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom Anti-Migraine Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia Anti-Migraine Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy Anti-Migraine Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific Anti-Migraine Drugs Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific Anti-Migraine Drugs Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific Anti-Migraine Drugs Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Anti-Migraine Drugs Revenue Market Share by Region (2017-2028)
Figure 56. China Anti-Migraine Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Anti-Migraine Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea Anti-Migraine Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Anti-Migraine Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Anti-Migraine Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Anti-Migraine Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Anti-Migraine Drugs Sales Market Share by Type (2017-2028)
Figure 63. South America Anti-Migraine Drugs Sales Market Share by Application (2017-2028)
Figure 64. South America Anti-Migraine Drugs Sales Market Share by Country (2017-2028)
Figure 65. South America Anti-Migraine Drugs Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Anti-Migraine Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Anti-Migraine Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa Anti-Migraine Drugs Sales Market Share by Type (2017-2028)
Figure 69. Middle East & Africa Anti-Migraine Drugs Sales Market Share by Application (2017-2028)
Figure 70. Middle East & Africa Anti-Migraine Drugs Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa Anti-Migraine Drugs Revenue Market Share by Region (2017-2028)
Figure 72. Turkey Anti-Migraine Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt Anti-Migraine Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Anti-Migraine Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa Anti-Migraine Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of Anti-Migraine Drugs in 2021
Figure 77. Manufacturing Process Analysis of Anti-Migraine Drugs
Figure 78. Anti-Migraine Drugs Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source
Global Narcolepsy Drug Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 80
According to our LPI (LP Information) latest study, the global Narcolepsy Drug market size was valued at US$ 2715.1 million in 2023. With growing demand in downstream market, the Narcolepsy Drug is forecast to a readjusted size of US$ 5598.9 million by 2030 with a CAGR of 10.9% during review period.
The research report highlights the growth potential of the global Narcolepsy Drug market. Narcolepsy Drug are expected to show stable growth in the future market. However, product differentia......
Global Epilepsy Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 04-Jan-2024 Price: US 3380 Onwards Pages: 121
Market Overview of Global Epilepsy Drugs market:
According to our latest research, the global Epilepsy Drugs market looks promising in the next 5 years. As of 2022, the global Epilepsy Drugs market was estimated at USD 4815.92 million, and it's anticipated to reach USD 6053.85 million in 2028, with a CAGR of 3.89% during the forecast years.
Anti-epileptic drugs can eliminate or reduce seizures in two ways. One is to affect central neurons to prevent or reduce their pathologic......
Global Neuromyelitis Optica Drug Market Growth (Status and Outlook) 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 107
According to our LPI (LP Information) latest study, the global Neuromyelitis Optica Drug market size was valued at US$ 46 million in 2023. With growing demand in downstream market, the Neuromyelitis Optica Drug is forecast to a readjusted size of US$ 57 million by 2030 with a CAGR of 3.1% during review period.
The research report highlights the growth potential of the global Neuromyelitis Optica Drug market. Neuromyelitis Optica Drug are expected to show stable growth in the future marke......
Migraine Drugs - Global Market Insights and Sales Trends 2024
Published: 25-Dec-2023 Price: US 3350 Onwards Pages: 118
The global Migraine Drugs market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Migraine Drugs in various end use industries. The expanding demands from the Hospitals, Clinics, Household Use and Others, are propelling Migraine Drugs market. Sumatriptan, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in......
Global Neuromyelitis Optica Drug Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 19-Dec-2023 Price: US 3380 Onwards Pages: 121
Market Overview of Global Neuromyelitis Optica Drug market:
According to our latest research, the global Neuromyelitis Optica Drug market looks promising in the next 5 years. As of 2022, the global Neuromyelitis Optica Drug market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years.
This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the glo......
Global Narcolepsy Drug Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 05-Dec-2023 Price: US 3380 Onwards Pages: 126
Market Overview of Global Narcolepsy Drug market:
According to our latest research, the global Narcolepsy Drug market looks promising in the next 5 years. As of 2022, the global Narcolepsy Drug market was estimated at USD 2915.59 million, and it's anticipated to reach USD 5983.81 million in 2028, with a CAGR of 12.73% during the forecast years.
Narcolepsy is a neurological disorder characterized by the brain's inability to control sleep/wakefulness cycles.
This......
Global Edaravone Market Research Report 2023
Published: 05-Dec-2023 Price: US 2900 Onwards Pages: 88
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Edaravone market with multiple angles, which provides sufficient supports to readers' strategy and decision making.
By Company
- Mitsubishi Tanabe Pharma
- Simcere
- Taj Pharmaceuticals Ltd.
- Sun Pharmaceutical Industries Ltd.
- Unichem Laboratories Ltd
- UCB India Ltd
- Piram......
Global Ethoxyquin Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 16-Nov-2023 Price: US 3380 Onwards Pages: 101
Market Overview of Global Ethoxyquin market:
According to our latest research, the global Ethoxyquin market looks promising in the next 5 years. As of 2022, the global Ethoxyquin market was estimated at USD 216.07 million, and it's anticipated to reach USD 303.42 million in 2028, with a CAGR of 5.82% during the forecast years.
Ethoxyquin (EQ) is a clear, viscous, light yellow to dark brown liquid, with an unpleasant, mercaptan-like smell, that causes irritation of the skin an......
Global Antipsychotic Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 12-Oct-2023 Price: US 3380 Onwards Pages: 117
Market Overview of Global Antipsychotic Drugs market:
According to our latest research, the global Antipsychotic Drugs market looks promising in the next 5 years. As of 2022, the global Antipsychotic Drugs market was estimated at USD 15363.6 million, and it's anticipated to reach USD 23658.8 million in 2028, with a CAGR of 7.46% during the forecast years.
This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global An......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
